Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Sep 29, 2023. (Total: 221560Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 7 (of 7 Records)

Query Trace: Recurrence and CYP19A1[original query]
Genetic polymorphisms of the CYP19A1 gene and breast cancer survival.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006 Nov 15 (11): 2115-22.
Long Ji-Rong, Kataoka Nobuhiko, Shu Xiao-Ou, Wen Wanqing, Gao Yu-Tang, Cai Qiuyin, Zheng W
Polymorphisms of CYP19A1 and response to aromatase inhibitors in metastatic breast cancer patients.
Breast cancer research and treatment 2012 Jun 133 (3): 1191-8.
Ferraldeschi Roberta, Arnedos Monica, Hadfield Kristen D, A'Hern Roger, Drury Suzie, Wardley Andrew, Howell Anthony, Evans D Gareth, Roberts Stephen A, Smith Ian, Newman William G, Dowsett Mit
Research on aromatase gene (CYP19A1) polymorphisms as a predictor of endocrine therapy effectiveness in breast cancer.
Revista medico-chirurgical?? a Societ????ii de Medici ??i Naturali??ti din Ia??i 0 116 (4): 997-1004.
Miron L, Negur? L, Peptanariu D, Marinca
CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial.
Breast cancer research and treatment 2015 Jun 151 (2): 373-84.
Leyland-Jones Brian, Gray Kathryn P, Abramovitz Mark, Bouzyk Mark, Young Brandon, Long Bradley, Kammler Roswitha, Dell'Orto Patrizia, Biasi Maria Olivia, Thürlimann Beat, Lyng Maria B, Ditzel Henrik J, Harvey Vernon J, Neven Patrick, Treilleux Isabelle, Rasmussen Birgitte Bruun, Maibach Rudolf, Price Karen N, Coates Alan S, Goldhirsch Aron, Pagani Olivia, Viale Giuseppe, Rae James M, Regan Meredith
Polymorphisms in ABCB1 and CYP19A1 genes affect anastrozole plasma concentrations and clinical outcomes in postmenopausal breast cancer patients.
British journal of clinical pharmacology 2016 Oct .
Gervasini Guillermo, Jara Carlos, Olier Clara, Romero Nuria, Martínez Ruth, Carrillo Juan Anton
Further Evidence That OPG rs2073618 Is Associated With Increased Risk of Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors for Early Breast Cancer.
Frontiers in genetics 2021 12 662734.
Hertz Daniel L, Smith Karen Lisa, Zong Yuhua, Gersch Christina L, Pesch Andrea M, Lehman Jennifer, Blackford Amanda L, Henry N Lynn, Kidwell Kelley M, Rae James M, Stearns Ver
The Prognostic Impact of Intratumoral Aryl Hydrocarbon Receptor in Primary Breast Cancer Depends on the Type of Endocrine Therapy: A Population-Based Cohort Study.
Frontiers in oncology 2021 6 11 642768.
Tryggvadottir Helga, Sandén Emma, Björner Sofie, Bressan Alessandra, Ygland Rödström Maria, Khazaei Somayeh, Edwards Dean P, Nodin Björn, Jirström Karin, Isaksson Karolin, Borgquist Signe, Jernström Hele
TOP